Ratings by TD Cowen (Steve Scala)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/17/2024 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 2/9/2024 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 1/4/2024 | Merck | MRK | Upgrade | Buy (Hold) |
114.77 (130.72) |
13.9% | Details | |
| 1/4/2024 | Pfizer | PFE | Downgrade | Hold (Buy) |
29.73 (25.26) |
-15.04% | Details | |
| 9/26/2023 | Elanco Animal Health | ELAN | Maintain | Buy (N/A) |
|
Details | ||
| 9/15/2023 | Bristol-Myers Squibb Co. | BMY | Maintain | Hold (N/A) |
|
Details | ||
| 9/15/2023 | Bristol-Myers Squibb Co. | BMY | Maintain | Buy (N/A) |
|
Details | ||
| 9/12/2023 | Roche | RHHBY | Maintain | Hold (N/A) |
|
Details | ||
| 5/23/2023 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 1/3/2023 | Merck | MRK | Maintain | Hold (N/A) |
|
Details | ||
| 12/5/2022 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2022 | Roche | RHHBY | Downgrade | Hold (Buy) |
43.25 (30.02) |
-30.59% | Details | |
| 9/12/2022 | Bristol-Myers Squibb Co. | BMY | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2022 | Zoetis Inc. | ZTS | Maintain | Buy (N/A) |
|
Details | ||
| 6/27/2022 | Merck | MRK | Maintain | Hold (N/A) |
|
Details | ||
| 6/27/2022 | Roche | RHHBY | Maintain | Buy (N/A) |
|
Details | ||
| 6/16/2022 | EQRx, Inc. | EQRX | Maintain | Buy (N/A) |
|
Details | ||
| 4/22/2022 | EQRx, Inc. | EQRX | New Coverage | Buy (N/A) |
4.42 (2.34) |
-47.06% | Details | |
| 4/14/2022 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 1/18/2022 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 12/20/2021 | Pfizer | PFE | Maintain | Buy (N/A) |
|
Details | ||
| 12/9/2021 | Zoetis Inc. | ZTS | Maintain | Buy (N/A) |
|
Details | ||
| 8/30/2021 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 8/23/2021 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 6/24/2021 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 6/3/2021 | Organon & Co. | OGN | New Coverage | Hold (N/A) |
8.00 (18.42) |
130.25% | Details | |
| 3/18/2021 | AstraZeneca | AZN | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2021 | Elanco Animal Health | ELAN | Maintain | Buy (N/A) |
|
Details | ||
| 2/12/2021 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 2/1/2021 | Novartis | NVS | Downgrade | Hold (Buy) |
90.47 (99.06) |
9.49% | Details | |
| 12/10/2020 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 12/3/2020 | Elanco Animal Health | ELAN | Maintain | Buy (N/A) |
|
Details | ||
| 11/30/2020 | AstraZeneca | AZN | Maintain | Buy (N/A) |
|
Details | ||
| 9/8/2020 | Merck | MRK | Maintain | Hold (N/A) |
|
Details | ||
| 8/10/2020 | Zoetis Inc. | ZTS | Maintain | Buy (N/A) |
|
Details | ||
| 7/13/2020 | Royalty Pharma | RPRX | New Coverage | Buy (N/A) |
47.64 (28.11) |
-40.99% | Details | |
| 6/30/2020 | Merck | MRK | Maintain | Hold (N/A) |
|
Details | ||
| 6/29/2020 | Bristol-Myers Squibb Co. | BMY | Maintain | Hold (N/A) |
|
Details | ||
| 6/18/2020 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 6/10/2020 | AstraZeneca | AZN | Maintain | Buy (Buy) |
|
Details | ||
| 5/19/2020 | Elanco Animal Health | ELAN | Maintain | Buy (N/A) |
|
Details | ||
| 2/18/2020 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 2/18/2020 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2020 | Novartis | NVS | Maintain | Buy (N/A) |
|
Details | ||
| 12/26/2019 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 12/11/2019 | Sanofi-Aventis | SNY | Maintain | Hold (N/A) |
|
Details | ||
| 12/2/2019 | AstraZeneca | AZN | Maintain | Buy (N/A) |
|
Details | ||
| 11/18/2019 | Bristol-Myers Squibb Co. | BMY | Maintain | Hold (N/A) |
|
Details | ||
| 11/12/2019 | Roche | RHHBY | Maintain | Buy (N/A) |
|
Details | ||
| 9/24/2019 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 9/5/2019 | Zoetis Inc. | ZTS | Maintain | Buy (N/A) |
|
Details | ||
| 6/17/2019 | Bristol-Myers Squibb Co. | BMY | Maintain | Hold (N/A) |
|
Details | ||
| 5/21/2019 | Novartis | NVS | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2019 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 4/1/2019 | AstraZeneca | AZN | Upgrade | Buy (Hold) |
42.98 (75.03) |
74.57% | Details | |
| 2/13/2019 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 11/26/2018 | Novartis | NVS | Upgrade | Buy (Hold) |
89.03 (90.47) |
1.62% | Details | |
| 10/15/2018 | Elanco Animal Health | ELAN | New Coverage | Buy (N/A) |
32.39 (13.04) |
-59.74% | Details | |
| 9/6/2018 | Pfizer | PFE | Maintain | Buy (N/A) |
|
Details | ||
| 8/22/2018 | Roche | RHHBY | Maintain | Buy (N/A) |
|
Details |
